Tauns Laboratories Inc
TSE:197A
Tauns Laboratories Inc
TAUNS Laboratories, Inc. develops and manufactures vitro diagnostic drugs & measuring instruments. The company is headquartered in Izunokuni-Shi, Shizuoka-Ken and currently employs 316 full-time employees. The company went IPO on 2024-06-20. The firm operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.
TAUNS Laboratories, Inc. develops and manufactures vitro diagnostic drugs & measuring instruments. The company is headquartered in Izunokuni-Shi, Shizuoka-Ken and currently employs 316 full-time employees. The company went IPO on 2024-06-20. The firm operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.